FindTrial
Sign In

CMF regimen

DRUG17 trials

Sponsors

Leiden University Medical Center, NCIC Clinical Trials Group, Scottish Cancer Therapy Network, Institute of Cancer Research, United Kingdom, Grupo Oncologico Cooperativo del Sur

Conditions

Breast CancerNeuroendocrine Carcinoma of the Skin

Phase 2

Combination Chemotherapy in Treating Women With Resected Breast Cancer
NCT00033683
Institute of Cancer Research, United KingdomBreast Cancer
Start: 2001-02-28Updated: 2009-02-09
Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
CompletedNCT00036868
European Organisation for Research and Treatment of Cancer - EORTCBreast Cancer
Start: 2002-02-28End: 2010-02-28Updated: 2024-03-08
Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
NCT00012311
Herbert Irving Comprehensive Cancer CenterBreast Cancer
Start: 2000-01-31Updated: 2014-01-06
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
CompletedNCT00003953
Case Comprehensive Cancer CenterBreast Cancer
Start: 1999-02-28End: 2013-01-31Updated: 2013-01-28
S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
CompletedNCT00003549
SWOG Cancer Research NetworkNeuroendocrine Carcinoma of the Skin
Start: 1998-10-31End: 2003-01-31Updated: 2012-10-08
Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
NCT00002498
Leiden University Medical CenterBreast Cancer
Start: 1992-07-31Updated: 2013-12-18

Phase 3

Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
CompletedNCT00003893
University Hospital BirminghamBreast Cancer
Start: 1998-07-31End: 2006-04-30Target: 2250Updated: 2013-12-19
Chemotherapy Plus Surgery in Treating Women With Breast Cancer
CompletedNCT00003013
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoBreast Cancer
Start: 1996-10-31End: 2009-03-31Target: 450Updated: 2013-09-17
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
CompletedNCT00003577
University Hospital BirminghamBreast Cancer
Start: 1996-03-31End: 2008-09-30Target: 2000Updated: 2013-12-19
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
SuspendedNCT00002696
Grupo Oncologico Cooperativo del SurBreast Cancer
Start: 1995-10-31Updated: 2013-08-02
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
CompletedNCT00002582
Institute of Cancer Research, United KingdomBreast Cancer
Start: 1993-06-30End: 2007-04-30Target: 6000Updated: 2013-08-02
Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
CompletedNCT00003012
Scottish Cancer Therapy NetworkBreast Cancer
Start: 1996-10-31Target: 1000Updated: 2013-11-06
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
NCT00003680
Scottish Cancer Therapy NetworkBreast Cancer
Start: 1998-11-30Target: 300Updated: 2013-11-06
Tamoxifen in Treating Women With High-Risk Breast Cancer
CompletedNCT00002542
NCIC Clinical Trials GroupBreast Cancer
Start: 1993-07-20End: 2011-01-11Updated: 2020-04-01
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
CompletedNCT00002784
ETOP IBCSG Partners FoundationBreast Cancer
Start: 1996-06-30End: 2011-12-31Updated: 2013-04-04
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
CompletedNCT00002579
Scottish Cancer Therapy NetworkBreast Cancer
Start: 1993-03-31Target: 2000Updated: 2013-11-06
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
CompletedNCT00002755
Scottish Cancer Therapy NetworkBreast Cancer
Start: 1995-11-30End: 1999-06-30Target: 600Updated: 2013-11-06

Related Papers

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
2019-11-2710 citations
Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data Repository.
2017-11-2311 citations
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.
2017-07-0122 citations
Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.
2016-02-0621 citations
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.
2015-04-20231 citations
Abstract 5545: Rare genetic variation association with neurotoxicity and infection in breast cancer patients enrolled in PG-SNPS
Cancer Research2014-10-01
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
2014-06-09595 citations